» Articles » PMID: 102086

Excretion and Biotransformation of Carboxymethyl-cysteine in Rat, Dog, Monkey and Man

Overview
Journal Xenobiotica
Publisher Informa Healthcare
Specialties Biochemistry
Toxicology
Date 1978 Oct 1
PMID 102086
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

1. Following an oral dose of S-carboxymethyl [35S]cysteine monkey (rhesus and African green), rat, dog, and man excreted 77,88,95, and 100% respectively of the 35S radioactivity in urine and 7.0, 2.5, 0.7, and 0.3% in faeces during a 3 to 4 day period. 2. The principal drug-related components excreted were unchanged carboxymethylcysteine, dicarboxymethyl sulphide and inorganic sulphate. 3. Rat, dog, and man excreted primarily dicarboxymethyl sulphide and unchanged carboxymethylcysteine and no inorganic sulphate (rat, 7%). 4. Monkey excreted largely inorganic sulphate, moderate amounts of dicarboxymethyl sulphide and a trace of unchanged drug.

Citing Articles

Variation in human metabolism of S-carboxymethylcysteine.

Waring R Eur J Drug Metab Pharmacokinet. 1980; 5(1):49-52.

PMID: 7389752 DOI: 10.1007/BF03189444.


Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Mitchell S, Waring R, Haley C, Idle J, Smith R Br J Clin Pharmacol. 1984; 18(4):507-21.

PMID: 6487492 PMC: 1463607. DOI: 10.1111/j.1365-2125.1984.tb02498.x.


An investigation of the metabolism of S-carboxymethyl-L-cysteine in man using a novel HPLC-ECD method.

Karim E, Millership J, Temple D, Woolfson A Eur J Drug Metab Pharmacokinet. 1988; 13(4):253-6.

PMID: 3243319 DOI: 10.1007/BF03190087.


High pressure liquid chromatographic determination of carbocisteine in human plasma and urine.

Bron J Pharm Weekbl Sci. 1986; 8(2):134-8.

PMID: 3086832 DOI: 10.1007/BF02086147.


Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.

Brockmoller J, Staffeldt B, Roots I Eur J Clin Pharmacol. 1991; 40(4):387-92.

PMID: 2050173 DOI: 10.1007/BF00265849.